Literature DB >> 1083199

Mechanisms of ampicillin resistance in Haemophilus influenzae type B.

R Vega, H L Sadoff, M J Patterson.   

Abstract

The genetic mechanisms associated with ampicillin resistance in strains of Haemophilus influenzae type b were investigated. In experiments concerned with transfer of total deoxyribonucleic acid in vitro, expression of resistance by wild-type strains occurred at a frequency of about 10%. The minimum inhibitory concentration of ampicillin for the transformed strains was similar to that of the resistant donor strains, and resistance in transformants was associated with acquisition of the ability to produce beta-lactamase. Exposure to 39 mug of acridine per ml for 18 h cured resistance at a frequency of 80%, and there was spontaneous loss of resistance after repeated subculture of some strains. Analysis by cesium chloride-ethidium bromide density gradient centrifugation demonstrated the presence of extrachromosomal deoxyribonucleic acid in the resistant strains, providing further evidence that the resistance factor is plasmid mediated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083199      PMCID: PMC429493          DOI: 10.1128/AAC.9.1.164

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease?

Authors:  J D Nelson
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

2.  Haemophilus influenzae type B resistant to ampicillin. A report of two cases.

Authors:  W Khan; S Ross; W Rodriguez; G Controni; A K Saz
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

Review 3.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

4.  Letter: Ampicillin-resistant haemophilus influenzae.

Authors:  B A Gunn; J B Woodall; J F Jones; C Thornsberry
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

5.  Plasmid in Bacillus pumilus and the enhanced sporulation of plasmid-negative variants.

Authors:  P S Lovett
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

6.  A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol.

Authors:  F F Barrett; L H Taber; C R Morris; W B Stephenson; D J Clark; M D Yow
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

Review 7.  Bacterial transformation, with special reference to recombination process.

Authors:  R D Hotchkiss; M Gabor
Journal:  Annu Rev Genet       Date:  1970       Impact factor: 16.830

8.  Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production.

Authors:  C Thornsberry; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

9.  Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae.

Authors:  W E Farrar; N M O'Dell
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

10.  Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.

Authors:  A A Medeiros; T F O'Brien
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

View more
  15 in total

1.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Method for evaluating broth culture media: application to Haemophilus.

Authors:  A W Brinkley; T W Huber
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.

Authors:  In-Suk Kim; Chang-Seok Ki; Sunjoo Kim; Won Sup Oh; Kyong Ran Peck; Jae-Hoon Song; Kyungwon Lee; Nam Yong Lee
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Transferable chloramphenicol and ampicillin resistance in a strain of Haemophilus influenzae.

Authors:  L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

5.  Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan.

Authors:  Yumiko Sanbongi; Takahisa Suzuki; Yumi Osaki; Nami Senju; Takashi Ida; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  Plasmid-mediated chloramphenicol resistance in Haemophilus influenzae.

Authors:  B van Klingeren; J D van Embden; M Dessens-Kroon
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

7.  Relationships among some R plasmids found in Haemophilus influenzae.

Authors:  L P Elwell; J R Saunders; M H Richmond; S Falkow
Journal:  J Bacteriol       Date:  1977-07       Impact factor: 3.490

8.  Effect of the inoculum size on carbapenem susceptibilities of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae.

Authors:  Hiroo Miyazaki; Toshinobu Horii; Osanori Nagura; Takafumi Suda; Kingo Chida; Hirotoshi Nakamura
Journal:  Curr Microbiol       Date:  2008-09-25       Impact factor: 2.188

9.  Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis.

Authors:  Keiko Hasegawa; Naoko Chiba; Reiko Kobayashi; Somay Y Murayama; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.